BioXcel LLC 4
4 · BioXcel Therapeutics, Inc. · Filed Jun 29, 2021
Insider Transaction Report
Form 4
BioXcel Corp
10% Owner
Transactions
- Sale
Common Stock
2021-06-25$30.83/sh−473,250$14,589,493→ 8,546,750 total
Footnotes (1)
- [F1]On June 25, 2021, the Reporting Person sold 473,250 shares of common stock of the Issuer as a selling stockholder in an underwritten public secondary offering at a price to the public of $31.70 per share . The reported sale price reflects the price at which the Reporting Person sold shares to the underwriters after underwriting discounts and commissions.